Sentinel node detection failure due to defective labeling and large particle size of Tc-99m antimony sulfide colloid

Iranian Journal of Nuclear Medicine

Volumn 19, Issue 1, 2011, Pages 6-11

  Sadri, Keyvan ^a   Ayati, Narjes Khatoon ^a   Shabani, Gholamali ^b   Zakavi, Seyed Rasoul ^a   Sadeghi, Ramin ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

Author keywords

Breast cancer; Lymphoscintigraphy; Sentinel node; Tc 99m antimony sulfide colloid

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M;

ADULT; ARTICLE; BREAST CANCER; CHEMICAL LABELING; CLINICAL ARTICLE; DIAGNOSTIC ERROR; HUMAN; LYMPHOSCINTIGRAPHY; PARTICLE SIZE; SENTINEL LYMPH NODE;

EID: 84855462543     PISSN: 16812824     EISSN: 20082509     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, et al. Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer. DARU 2009;17(2):83-87.
2. Mehrabibahar M, Forghani MN, Memar B, Jangjoo A, Dabbagh Kakhki VR, Zakavi SR, et al. Sentinel lymph node biopsy in melanoma patients: An experience with Tc- 99m Antimony Sulfide Colloid. Iran J Nucl Med. 2010;18(1):1-6.
3. Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol. 2008 Jul;15(7):1996-2005.
4. Goyal A, Mansel RE. Recent advances in sentinel lymph node biopsy for breast cancer. Curr Opin Oncol. 2008 Nov;20(6):621-6.
5. Pritsivelis C, Garcia Mendonça CA, Pinheiro Pessoa MC, Coelho-Oliveira A, Gutfilen B, Barbosa Da Fonseca LM. Failure predictors of the sentinel lymph node in patients with breast cancer using Tc-99m sulfur colloid and periareolar injection. Q J Nucl Med Mol Imaging. 2007 Jun;51(2):189-93. (Pubitemid 47064659)
6. Sadeghi R, Forghani MN, Memar B, Abdollahi A, Zakavi SR, Mashhadi MT et al. Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes. Hell J Nucl Med. 2009 Jan-Apr;12(1):30-2.
7. Eshima D, Fauconnier T, Eshima L, Thornback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med. 2000 Jan;30(1):25-32. (Pubitemid 30059087)
8. Sadeghi R, Forghani MN, Memar B, Rajabi Mashhadi MT, Dabbagh Kakhki VR, Abdollahi A et al. How long the lymphoscintigraphy imaging should be continued for sentinel lymph node mapping? Ann Nucl Med. 2009 Aug;23(6):507-10. 9.
9. Núñez EG, Faintuch BL, Teodoro R, Wiecek DP, Martinelli JR, da Silva NG et al. Influence of colloid particle profile on sentinel lymph node uptake. Nucl Med Biol. 2009 Oct;36(7):741-7.
10. Sato K, Krag D, Tamaki K, Anzai M, Tsuda H, Kosuda S et al. Optimal particle size of radiocolloid for sentinel node identification in breast cancer-electron microscopic study and clinical comparison. Breast Cancer. 2004;11(3):256-63; discussion 264-6.
11. Higashi H, Natsugoe S, Uenosono Y, Ehi K, Arigami T, Nakabeppu Y et al. Particle size of tin and phytate colloid in sentinel node identification. J Surg Res. 2004 Sep;121(1):1-4. (Pubitemid 39094088)
12. Gommans GM, van Dongen A, van der Schors TG, Gommans E, Visser JF, Clarijs WW et al. Further optimisation of 99mTc- Nanocoll sentinel node localisation in carcinoma of the breast by improved labelling. Eur J Nucl Med. 2001 Oct;28(10):1450-5.
13. Jimenez IR, Roca M, Vega E, García ML, Benitez A, Bajén M et al. Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nucl Med Commun. 2008 Feb;29(2):166-72. (Pubitemid 350306775)
14. Bensimhon L, Métayé T, Guilhot J, Perdrisot R. Influence of temperature on the radiochemical purity of 99mTc-colloidal rhenium sulfide for use in sentinel node localization. Nucl Med Commun. 2008 Nov;29(11):1015-20.
15. Shabani GA, Hamzeh H, Najafi R. Production of 99mTc-Antimony sulfide colloid for lymphoscintigraphy. Iran J Nucl Med. 2003;19:57-65.
16. Abdollahi A, Jangjoo A, Dabbagh Kakhki VR, Rasoul Zakavi S, Memar B, Naser Forghani M et al. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer. Rev Esp Med Nucl. 2010 Mar- Apr;29(2):73-7.
17. Uren RF, Thompson JF, Howman-Giles R, Roberts JM. Sentinel lymph node detection and imaging. Eur J Nucl Med. 1999;26(8):936-938.
18. Paganelli G, De Cicco C, Cremonesi M, Prisco G, Calza P, Luini A et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med. 1998 Mar;42(1):49-53. (Pubitemid 28244267)
19. Wilhelm AJ, Mijnhout GS, Franssen EJ. Radiopharmaceuticals in sentinel lymphnode detection - an overview. Eur J Nucl Med. 1999 Apr;26(4 Suppl):S36-42. (Pubitemid 29171617)
20. Jangjoo A, Shabani GA, Zakavi R, Dabbagh Kakhki VR, Sadeghi R. Disappearance of a sentinel node on the delayed lymphoscintigraphy imaging of a breast cancer patient: Importance of blue dye injection. NOWOTWORY J Oncol. 2011;61(1):30-31.
21. Qaiser Shah S. New technology of technetium-99 labeled antimony trisulfide colloid intended for sentinel lymph node imaging. Pharm Chem J. 2006;40(3):151-154. (Pubitemid 44306159)
22. Sadeghi R. Sentinel node biopsy in medical practice: more than 6 years of practice in Mashhad. Iran J Nucl Med. 2010;18(Suppl 1):56.